Literature DB >> 3782462

Comparison of cerebrospinal fluid C-reactive protein and lactate for diagnosis of meningitis.

R A Komorowski, S G Farmer, K K Knox.   

Abstract

Levels of C-reactive protein and lactate were determined on 562 consecutive cerebrospinal fluid (CSF) samples from adult patients with a wide variety of central nervous system diseases to compare the sensitivity and specificity of CSF lactate and C-reactive protein for the rapid diagnosis of bacterial meningitis. Neither test alone, together, or in combination with elevated CSF leukocyte count and protein had a predictive value over 60% for a positive test in this group of patients with diverse central nervous system problems. Neither test is useful as a screening test for bacterial or mycotic meningitis. Also, in patients with partially treated bacterial meningitis, the tests are often negative. CSF lactate may be useful in differentiating aseptic from septic meningitis in selected patients.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3782462      PMCID: PMC269083          DOI: 10.1128/jcm.24.6.982-985.1986

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  14 in total

1.  A clinical evaluation of the C-reactive protein test.

Authors:  A A DOERNER; R S YOCUM
Journal:  AMA Arch Intern Med       Date:  1957-01

2.  C-reactive protein as predictor of sequelae of meningitis.

Authors:  P Valmari; H Peltola; O Ruuskanen
Journal:  Lancet       Date:  1984-03-31       Impact factor: 79.321

3.  C-reactive protein in case of consecutive bacterial and viral meningitis.

Authors:  F de Zegher; E Ben Gershôm; G J Briggeman-Mol
Journal:  Lancet       Date:  1984-12-22       Impact factor: 79.321

4.  Cerebrospinal fluid C-reactive protein in neonatal meningitis.

Authors:  A G Philip; C J Baker
Journal:  J Pediatr       Date:  1983-05       Impact factor: 4.406

5.  The diagnostic utility of C-reactive protein.

Authors:  F Van Lente
Journal:  Hum Pathol       Date:  1982-12       Impact factor: 3.466

6.  Rapid enzymatic measurement of blood lactate and pyruvate. Use and significance of metaphosphoric acid as a common precipitant.

Authors:  E P Marbach; M H Weil
Journal:  Clin Chem       Date:  1967-04       Impact factor: 8.327

7.  C-reactive protein for rapid monitoring of infections of the central nervous system.

Authors:  H O Peltola
Journal:  Lancet       Date:  1982-05-01       Impact factor: 79.321

8.  C-reactive protein in spinal fluid of children with meningitis.

Authors:  C J Corrall; J M Pepple; E R Moxon; W T Hughes
Journal:  J Pediatr       Date:  1981-09       Impact factor: 4.406

9.  Cerebrospinal fluid lactic acid in diagnosis of meningitis.

Authors:  R A Komorowski; S G Farmer; G A Hanson; L L Hause
Journal:  J Clin Microbiol       Date:  1978-07       Impact factor: 5.948

10.  Is C-reactive protein useful in the management of children with suspected bacterial meningitis?

Authors:  D R Benjamin; K E Opheim; L Brewer
Journal:  Am J Clin Pathol       Date:  1984-06       Impact factor: 2.493

View more
  4 in total

1.  Eosinopenia as a marker of diagnosis and prognostic to distinguish bacterial from aseptic meningitis in pediatrics.

Authors:  Agathe Debray; Sylvie Nathanson; Florence Moulin; Jérome Salomon; Benjamin Davido
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-06-22       Impact factor: 3.267

2.  Biographical feature: Silas G. Farmer, Ph.D.

Authors:  Gary V Doern
Journal:  J Clin Microbiol       Date:  2013-12-04       Impact factor: 5.948

3.  Value of cerebrospinal fluid analysis in the differential diagnosis of meningitis: a study in 710 patients with suspected central nervous system infection.

Authors:  L Lindquist; T Linné; L O Hansson; M Kalin; G Axelsson
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-06       Impact factor: 3.267

4.  C - reactive protein of cerebrospinal fluid, as a sensitive approach for diagnosis of neonatal meningitis.

Authors:  Shima Javadinia; Mohsen Tabasi; Mehri Naghdalipour; Najmosadat Atefi; Ramin Asgarian; Jamil Kheirvari Khezerloo; Azardokht Tabatabaei
Journal:  Afr Health Sci       Date:  2019-09       Impact factor: 0.927

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.